A unified report merging genetic and microbiome data for a complete precision-medicine perspective on drug response.
Our flagship integrated report combines pharmacogenomic data with microbiome analysis to deliver a holistic view of how a patient metabolizes and responds to medications. This unified report correlates genetic polymorphisms with microbial metabolic pathways, providing clinicians with unprecedented insight for precision prescribing. It includes risk stratification, drug interaction alerts, and evidence-based therapeutic recommendations.
Reach out to discuss how this service can be integrated into your clinical workflow.
Contact Us